<bill session="118" type="s" number="2198" updated="2025-11-19T03:04:20Z">
  <state datetime="2023-06-22">REFERRED</state>
  <status>
    <introduced datetime="2023-06-22"/>
  </status>
  <introduced datetime="2023-06-22"/>
  <titles>
    <title type="display">Prescription Drug Supply Chain Pricing Transparency Act</title>
    <title type="short" as="introduced">Prescription Drug Supply Chain Pricing Transparency Act</title>
    <title type="official" as="introduced">A bill to require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.</title>
  </titles>
  <sponsor bioguide_id="B001267"/>
  <cosponsors>
    <cosponsor bioguide_id="L000575" joined="2023-06-22"/>
  </cosponsors>
  <actions>
    <action datetime="2023-06-22">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-06-22" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="s" number="2973" relation="unknown"/>
    <bill session="118" type="h" number="7535" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
</bill>
